Monoclonal and polyclonal humoral immune response to EC HER-2/neu peptides with low similarity to the host's proteome

International Journal of Cancer

Volumn 98, Issue 5, 2002, Pages 741-747

  Mittelman, Abraham ^a   Lucchese, Alberta ^b   Sinha, Animesh A ^c   Kanduc, Darja ^b  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF BARI   (Italy)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Breast prostate cancer; Epitope prediction; HER 2 neu; Molecular mimicry

Indexed keywords

AUTOANTIGEN; DESMOGLEIN; MONOCLONAL ANTIBODY; PROTEOME; TUMOR ANTIGEN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BREAST CANCER; CANCER IMMUNOLOGY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HOST; HUMAN; HUMORAL IMMUNITY; IMMUNOASSAY; MOLECULAR MIMICRY; MOUSE; NONHUMAN; ONCOGENE NEU; PRIORITY JOURNAL; PROSTATE CANCER; SERUM; UTERINE CERVIX CANCER;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY FORMATION; BREAST NEOPLASMS; COLONIC NEOPLASMS; COMPUTATIONAL BIOLOGY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; EPITOPES; FEMALE; HUMANS; MALE; MICE; MICE, INBRED BALB C; OLIGOPEPTIDES; PROSTATIC NEOPLASMS; PROTEOME; RECEPTOR, ERBB-2; UTERINE CERVICAL NEOPLASMS;

EID: 0037051685     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10259     Document Type: Article

References (33)

1. Direct identification of protein epitopes by mass spectrometry without immobilization of antibody and isolation of antibody-peptide complexes
2. Interactions of protein antigens with antibodies
3. Epitope prediction from the primary structure of proteins
4. Limited diversity of human scFv fragments isolated by panning a synthetic phage-display scFv library with cultured human melanoma cells
5. Molecular mimicry of phage displayed peptides mimicking GD3 ganglioside
6. Computer-assisted analysis of molecular mimicry between HPV16 E7 oncoprotein and human protein sequences
7. Individuation of monoclonal anti-HPV16 E7 antibody linear peptide epitope by computational biology
8. Computer-driven individuation of mouse monoclonal antidesmoglein 3 antibody defined epitopic peptide sequence
9. Vaccination with the extra-cellular domain of p185neu prevents mammary tumor development in neu transgenic mice
10. Flexible sequence similarity searching with the FASTA3 program package
11. PIR-ALN: A database of protein sequence alignments
12. The role SWlSS-PROT and TrEMBL play in the genome research environment
13. PRINTS prepares for the new millennium
14. A subclass of tumor-inhibitory monoclonal antibodies to ErbB-2/HER2 blocks crosstalk with growth factor receptors
15. Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer
16. Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: Implications for human breast cancer
17. Neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer
18. HER-2/neu protein: A target for antigen-specific immunotherapy of human cancer
19. Relative cytotoxic activity of immunotoxins reactive with different epitopes on the extracellular domain of the c-erbB-2 (HER-2/neu) gene product p185
20. Antigenic and immunogenic mimicry of the HER2/neu oncoprotein by phage-displayed peptides
21. Mechanisms of T cell recognition with application to vaccine design
22. Antigen-presenting cells and the selection of immunodominant epitopes
23. Cutting edge: Introduction of an endopeptidase cleavage motif into a determinant flanking region of hen egg lysozyme results in enhanced T cell determinant display
24. Protein antigenic structures recognized by T cells: Potential applications to vaccine design
25. SYFPEITHI: Database for MHC ligands and peptide motifs
26. In vivo CTL induction with point-substituted ovalbumin peptides: Immunogenicity correlates with peptide-induced MHC class I stability
27. T-cell antigenic sites tend to be amphipathic structures
28. Prediction of immunodominant helper T cell antigenic sites from the primary sequence
29. Tolerance and cancer: A critical issue in tumor immunology
30. Developing recombinant and synthetic vaccines for the treatment of melanoma
31. Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine
32. Molecular mimicry and immune-mediated diseases